Boehringer Ingelheim

C.H. Boehringer Sohn AG & Co. KG

Company type	Privately held Kommanditgesellschaft with an Aktiengesellschaft as general partner
Industry	Pharmaceuticals
Founded	1885; 139 years ago (1885) in Ingelheim am Rhein, Germany
Founder	Albert Boehringer
Headquarters	Ingelheim , Germany
Area served	Worldwide
Key people	Hubertus von Baumbach, Chairman of the board, Michael Schmelmer, board member (CFO) Carinne Brouillon, board member Jean Scheftsik de Szolnok, board member Michel Pairet, board member Shashank Deshpande, board member Paola Casarosa, board member[1]
Products	Pharmaceuticals and Animal Health
Revenue	€25.6 billion (2023)[2]
Owner	Boehringer, Liebrecht and von Baumbach families
Number of employees	53,565 (2023)[2]
Website	boehringer-ingelheim.com

C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families.^[3] The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.^[4]